Support
Services
WHAT IS
TAIHO ONCOLOGY
PATIENT SUPPORT™?
Taiho Oncology Patient Support is your online and on‑call resource center for any questions or needs related to financial help and personal support for your LONSURF® (trifluridine and tipiracil) tablets treatment.
Insurance Help
Throughout the process including appeals
$0 Co-Pay*
And other cost help based on your healthcare coverage
Nurse Support
One-on-one educational guidance*For commercially insured, eligible patients
HOW TO ENROLL
Find out how you can get help with treatment costs, nurse support, and more.
There are 2 simple ways to enroll:
Download and Print
Download and print the Patient Enrollment Form and fill it in at your doctor's office with your doctor, nurse, or support staff.
By Phone
Call 1-844-TAIHO-4U
(1-844-824-4648) to enroll
by phone.
What happens once you enroll:
-
A Taiho Oncology Patient Support Reimbursement Specialist will call you to:
- Welcome you to the program
- Explain your insurance benefits
- Confirm your insurance coverage for LONSURF or help you apply for financial assistance
- The specialty pharmacy will call you to discuss payment and shipment, if applicable
- You will receive LONSURF from the specialty pharmacy, doctor's office, or hospital. Then you'll follow your healthcare provider's instructions for beginning treatment
- If you have signed up to be paired with a Nurse Navigator, he or she will stay in contact to help you with your treatment plan
Cost Help and $0 Co-pay
MAKING GETTING TREATMENT EASIER
Questions about insurance, costs, or prescriptions? These services are just a phone call away for eligible patients.
Insurance coverage and reimbursement support
Based on your eligibility, we are here to help you:
- Understand your insurance coverage for LONSURF and your out‑of‑pocket responsibility
- Determine prior authorization requirements from your insurance company
- Work with your insurance company if coverage is denied
Co-Pay savings for commercially insured eligible patients
- You may be eligible to receive a Co-Pay Card to help reduce your out‑of‑pocket costs for LONSURF to $0.†
Ask your healthcare provider or pharmacy for the Taiho Oncology Patient Support Co-Pay Card if you have commercial insurance
Alternate funding support for Medicare/Medicaid‑ or government‑insured
If you are Medicare/Medicaid- or government-insured, we will refer you to third-party organizations that may be able to provide you with co‑pay assistance.
Patient Assistance Program for those unable to afford LONSURF
We may be able to provide LONSURF to you free of charge if you have:
- No prescription insurance coverage
- Insufficient prescription insurance coverage
- Insufficient financial resources
Pharmacy coordination
We will be in contact with your pharmacy and your doctor, and will keep you up to date about your prescription status.
†Restrictions and eligibility: Offer valid in the US, Puerto Rico, and US territories only. Only valid for patients with private insurance. Offer not valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, Tricare, or other federal or state programs (such as medical assistance programs). If the patient is eligible for drug benefits under any such program, this offer is not valid and the patient cannot use this offer. By presenting or accepting this benefit, patient and pharmacist agree not to submit claim for reimbursement under the above programs. Patient further agrees to comply with any and all terms of his or her health insurance contract requiring notification to his or her payer of the existence and/or value of this offer. It is illegal to or offer to sell, purchase, or trade this benefit. Maximum reimbursement limits apply; patient out-of-pocket expense may vary. Taiho Oncology Inc., reserves the right to rescind, revoke, or amend this offer at any time without notice.
SEE ALL INDICATIONS
INDICATIONS
LONSURF is a prescription medicine used:
- alone or in combination with the medicine bevacizumab to treat adults with colorectal cancer:
- that has spread to other parts of the body, and
- who have been previously treated with certain chemotherapy medicines
- alone to treat adults with a kind of stomach cancer called gastric cancer including adenocarcinoma of the gastroesophageal junction:
- that has spread to other parts of the body, and
- who have been previously treated with at least 2 types of treatment which included certain medicines
It is not known if LONSURF is safe and effective in children.
INDICATIONS
LONSURF is a prescription medicine used:
- alone or in combination with the medicine bevacizumab to treat adults with colorectal cancer:
- that has spread to other parts of the body, and
- who have been previously treated with certain chemotherapy medicines
- alone to treat adults with a kind of stomach cancer called gastric cancer including adenocarcinoma of the gastroesophageal junction:
- that has spread to other parts of the body, and
- who have been previously treated with at least 2 types of treatment which included certain medicines
It is not known if LONSURF is safe and effective in children.
IMPORTANT SAFETY INFORMATION
LONSURF may cause serious side effects, including:
- Low blood counts. Low blood counts are common with LONSURF and can sometimes be severe and life-threatening. LONSURF can cause a decrease in your white blood cells, red blood cells, and platelets. Low white blood cells can make you more likely to get serious infections that could lead to death. Your healthcare provider should do blood tests before you receive LONSURF, at day 15 during treatment with LONSURF, and as needed to check your blood cell counts. Your healthcare provider may lower your dose of LONSURF or stop LONSURF if you have low white blood cell or platelet counts
Tell your healthcare provider right away if you get any of the following signs and symptoms of infection during treatment with LONSURF: fever, chills, or body aches.
Before taking LONSURF, tell your healthcare provider about all of your medical conditions, including if you:
- Have kidney or liver problems
- Are pregnant or plan to become pregnant. LONSURF can harm your unborn baby
- Females who can become pregnant: Your healthcare provider will do a pregnancy test before you start treatment with LONSURF. You should use effective birth control during and 6 months after the last dose of treatment with LONSURF. Tell your healthcare provider immediately if you become pregnant
- Males, while on treatment and for 3 months after your last dose of LONSURF, you should use a condom during sex with female partners who are able to become pregnant. Tell your healthcare provider right away if your partner becomes pregnant while you are taking LONSURF
- Are breastfeeding or plan to breastfeed. It is not known if LONSURF passes into your breast milk. Do not breastfeed during treatment with LONSURF and for 1 day after your last dose of LONSURF
Tell your healthcare provider about all the prescription and over-the-counter medicines, vitamins, and herbal supplements you take.
The most common side effects of LONSURF when used alone include low blood counts, tiredness and weakness, nausea, decreased appetite, diarrhea, vomiting, stomach-area (abdominal) pain, and fever.
The most common side effects of LONSURF when used in combination with bevacizumab include low blood counts, tiredness and weakness, nausea, certain abnormal liver function blood tests, decreased salt (sodium) in your blood, diarrhea, stomach-area (abdominal) pain, and decreased appetite.
Tell your healthcare provider if you have nausea, vomiting, or diarrhea that is severe or that does not go away.
These are not all of the possible side effects of LONSURF. For more information, ask your healthcare provider. Call your doctor for medical advice about side effects.